OPNT

Opiant Pharmaceuticals, Inc. Common Stock
OPNT

Overview Fund Activity
Delisted

OPNT was delisted on the 1st of March, 2023.

Back to rankings

23 hedge funds and large institutions have $11.1M invested in Opiant Pharmaceuticals, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
-3
Holders Change %
-11.54%
% of All Funds
0.51%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
5
Increased
8
Reduced
3
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SCM
Stonepine Capital Management
Oregon
$5.17M
2
EIM
Essex Investment Management
Massachusetts
$722K
3
PCM
Prelude Capital Management
New York
$350K
4
Vanguard Group
Vanguard Group
Pennsylvania
$1.78M
5
EP
Eversept Partners
New York
$201K

Top Sellers

1
HI
HBK Investments
Texas
$0
2
CLCM
Crawford Lake Capital Management
New Jersey
$0
3
SM
Sabby Management
Florida
$0
4
CH
CVI Holdings
Delaware
$0
5
UOC
UBS O'Connor
Illinois
$352K
Name Holding Trade Value Shares
Change 		Shares
Change %
SM
26
Sabby Management
Florida
– -$781K -43,736 Closed
CH
27
CVI Holdings
Delaware
– -$245K -13,715 Closed
OSAM
28
O'Shaughnessy Asset Management
Connecticut
– -$60K -3,343 Closed
Acadian Asset Management
29
Acadian Asset Management
Massachusetts
– -$44K -2,470 Closed
CC
30
Claybrook Capital
Massachusetts
– -$1K -50 Closed
1
2